Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase

被引：0
|
作者：
Lavoisier Ramos-Espiritu
Silke Kleinboelting
Felipe A Navarrete
Antonio Alvau
Pablo E Visconti
Federica Valsecchi
Anatoly Starkov
Giovanni Manfredi
Hannes Buck
Carolina Adura
Jonathan H Zippin
Joop van den Heuvel
J Fraser Glickman
Clemens Steegborn
Lonny R Levin
Jochen Buck
机构：
[1] Weill Cornell Medical College,Department of Pharmacology
[2] The High-Throughput Screening and Spectroscopy Resource Center,Department of Biochemistry
[3] The Rockefeller University,Department of Veterinary and Animal Science
[4] University of Bayreuth,Department of Dermatology
[5] University of Massachusetts,undefined
[6] Brain and Mind Research Institute,undefined
[7] Weill Cornell Medical College,undefined
[8] Weill Cornell Medical College,undefined
[9] Helmholtz Zentrum fur Infektionsforschung,undefined
来源：
Nature Chemical Biology | 2016年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A high-throughput screen using a mass-spectrometry-based assay results in the identification of LRE1 as an inhibitor of HCO3−/Ca2+-regulated soluble adenylyl cyclase activity. LRE1 interacts with the HCO3− binding site (BBS) to block cAMP formation.[graphic not available: see fulltext]
引用
收藏
页码：838 / 844
页数：6
相关论文
共 50 条
  • [41] Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor
    Parcella, Kyle
    Wang, Tao
    Eastman, Kyle
    Zhang, Zhongxing
    Yin, Zhiwei
    Patel, Manoj
    Tu, Yong
    Zheng, Barbara Zhizhen
    Walker, Michael A.
    Saulnier, Mark G.
    Frennesson, David
    Bowsher, Michael
    Gillis, Eric
    Peese, Kevin
    Belema, Makonen
    Cianci, Christopher
    Dicker, Ira B.
    McAuli, Brian
    Ding, Bo
    Falk, Paul
    Simmermacher, Jean
    Parker, Dawn D.
    Sivaprakasam, Prasanna
    Kish, Kevin
    Lewis, Hal
    Hanumegowda, Umesh
    Jenkins, Susan
    Kadow, John F.
    Krystal, Mark
    Meanwell, Nicholas A.
    Naidu, B. Narasimhulu
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (06): : 972 - 980
  • [42] Discovery of a First-In-Class Covalent Allosteric Inhibitor of SUMO E1 Activating Enzyme
    Magin, Robert S.
    Doherty, Laura M.
    Buhrlage, Sara J.
    CELL CHEMICAL BIOLOGY, 2019, 26 (02): : 153 - 155
  • [43] In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor nitric oxide cyclic GMP pathway
    Fedele, E
    Jin, Y
    Varnier, G
    Raiteri, M
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (03) : 590 - 594
  • [44] Gender-Specific Modulation of the Response to Arterial Injury by Soluble Guanylate Cyclase alpha 1
    Vermeersch, Pieter
    Buys, Emmanuel
    Sips, Patrick
    Pokreisz, Peter
    Marsboom, Glenn
    Gillijns, Hilde
    Pellens, Marijke
    Dewerchin, Mieke
    Bloch, Kenneth D.
    Brouckaert, Peter
    Janssens, Stefan
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2009, 3 : 98 - 104
  • [45] New aspects of adenylyl cyclase regulation:: The C1b domain as a key target for isoform-specific activators
    Diel, S
    Llorens, MN
    Kleuss, C
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R55 - R55
  • [46] The role of structure and biophysics in the discovery of allosteric kinase inhibitors: ABL001, a potent and specific inhibitor of BCR-ABL
    Cowan-Jacob, Sandra W.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2016, 72 : S4 - S5
  • [47] Rosmarinic Acid Present in Lepechinia floribunda and Lepechinia meyenii as a Potent Inhibitor of the Adenylyl Cyclase gNC1 from Giardia lamblia
    Zurita, Adolfo
    Hissi, Esteban Vega
    Romero, Agostina Cianci
    Lujan, Adela Maria
    Salido, Sofia
    Yaneff, Agustin
    Davio, Carlos
    Cobo, Justo
    Carpinella, Maria Cecilia
    Enriz, Ricardo Daniel
    PLANTS-BASEL, 2024, 13 (05):
  • [48] Discovery of CMPD1 as a tumor-specific cytotoxic microtubule inhibitor
    Takada, Mamoru
    Suzuki, Aussie
    Yamada, Hideyuki
    Yu, Muhan
    Nagashima, Takeshi
    Fujimoto, Hiroshi
    Sakakibara, Junta
    Otsuka, Masayuki
    CANCER SCIENCE, 2024, 115 : 720 - 720
  • [49] Discovery of CMPD1 as a tumor-specific cytotoxic microtubule inhibitor
    Takada, M.
    Chen, Y-C.
    Wang, J.
    Yamada, H.
    Yu, M.
    Sakakibara, J.
    Fujimoto, H.
    Nagashima, T.
    Ohtsuka, M.
    Takaku, M.
    Suzuki, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S213 - S214
  • [50] GLP-1[28-36] Exerts Direct Cardioprotective Effects, Activating Pro-Survival Kinases and Soluble Adenylyl Cyclase
    Mundil, Dhanwantee
    Beca, Sanja
    Cameron-Vendrig, Alison
    El-Mounayri, Omar
    Momen, Abdul
    Backx, Peter H.
    Husain, Mansoor
    CIRCULATION, 2012, 126 (21)
12345